cobas t 511 coagulation analyzer and cobas t 711 coagulation analyzer

Making innovation your routine

cobas t 511 / t 711 coagulation analyzer
The perfect fit for your testing needs

The cobas t 511 and the cobas t 711 coagulation analyzer give your lab the freedom to choose the perfect fit for your testing needs. 

 

Compare

Available Assays

Coagulation sample tubes

Different throughput needs.

Same standard of quality and innovation.

 

The right fit for every workload.

 

Because one size does not fit all, Roche offers two different options to benefit from the innovation brought to coagulation testing: the mid-throughput cobas t 511 coagulation analyzer, and the high-throughput cobas t 711 coagulation analyzer. 

cobas t 511 coagulation analyzer fron view
cobas t 511
coagulation analyzer
  • Throughput of 195 tests/hr
  • Sample capacity of 75
  • 57 reagent cassette positions for up to 34,200 tests on board
  • Sample integrity check: HIL index, Clog detection, Automatic cuvette checks
  • Sample loading and unloading is automated via front loading port
cobas t 711 coagulation analyzer fron view
cobas t 711
coagulation analyzer
  • Throughput of 390 tests/hr
  • Sample capacity of 225
  • 57 reagent cassette positions for up to 34,200 tests on board
  • Sample integrity check: HIL index, Clog detection, Automatic cuvette checks
  • Sample loading and unloading is automated via the front loading port and via the side balcony    
  • Connectivity to automation with the cobas® 8100 automated workflow series and the cobas® connection modules
    Laboratory automation
Coagulation samples
Available assays and tests

Antithrombin

In vitro assay for the quantitative determination of antithrombin activity in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of antithrombin deficiency.

Anti-Xa

In vitro assay for the quantitative determination of the anti-Xa activity of unfractionated (UFH) and low molecular weight (LMWH) heparins in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the management of anti-Xa Heparin therapy.

APC Resistance

APC Resistance is a functional assay for the determination of resistance of factor Va to inactivation by activated protein C (APC) caused by the factor V Leiden mutation (FV:R506Q) in citrated plasma on indicated cobas t analyzers.

aPTT

In vitro assay, with reduced lupus sensitivity, for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

aPTT Lupus

In vitro assay, with increased lupus sensitivity, for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

aPTT Screen

In vitro assay for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

D-Dimer

In vitro assay for the quantitative immunological determination of fibrin degradation products (D‑dimer and X‑oligomers) in human citrated plasma on the indicated cobas t analyzers. In conjunction with a non-high clinical probability assessment, a normal D‑dimer result (< 0.5 μg FEUa)/mL) is intended as an aid in the exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Fibrinogen

In vitro assay for the quantitative determination of fibrinogen (Clauss method) in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the detection of hypo- and hyperfibrinogenemia, dysfibrinogenemia and afibrinogenemia.

FII

Human plasma immunodepleted of Factor II for the quantitative determination of Factor II activity in citrated plasma, based on the prothrombin time (PT) assay, on the indicated cobas t analyzers.

Free Protein S

In vitro assay for the quantitative determination of free protein S in human citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of inherited and acquired protein S deficiency.

FV

Human plasma immunodepleted of Factor V for the quantitative determination of Factor V activity in citrated plasma, based on the prothrombin time (PT) assay, on the indicated cobas t analyzers.Human plasma immunodepleted of Factor II for the quantitative determination of Factor II activity in citrated plasma, based on the prothrombin time (PT) assay, on the indicated cobas t analyzers.

FVII

Human plasma immunodepleted of Factor VII for the quantitative determination of Factor VII activity in citrated plasma, based on the prothrombin time (PT) assay, on the indicated cobas t analyzers.

FVIII

Human plasma immunodepleted of Factor VIII for the quantitative determination of Factor VIII activity in citrated plasma, based on the activated partial thromboplastin time (aPTT) assay, on the indicated cobas t analyzers.

FX

Human plasma immunodepleted of Factor X for the quantitative determination of Factor X activity in citrated plasma, based on the prothrombin time (PT) assay, on the indicated cobas t analyzers.

HIL Test

In vitro test for the semi-quantitative determination of the lipemia index, hemolysis index and icterus index in citrated plasma on cobas t systems.

Lupus S, Lupus C

In vitro assays to screen for (Lupus S) and to confirm (Lupus C) the presence of lupus anticoagulants in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of anti‑phospholipid syndrome.

PT derived Fibrinogen

The derived fibrinogen result is intended as an aid in the diagnosis of a fibrinogen deficiency.

Protein C Chromogenic

In vitro chromogenic assay for the quantitative determination of Protein C activity in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of inherited and acquired Protein C deficiencies.

PT Owren

In vitro assay for the determination of the Owrens prothrombin time in citrated plasma on the indicated cobas t analyzers. The Owrens prothrombin time is intended as an aid in the management of vitamin K antagonist therapy.

PT Rec

In vitro assay for the determination of prothrombin time and derived fibrinogen in citrated plasma on the indicated cobas t analyzers. The prothrombin time is used for evaluation of the extrinsic coagulation pathway and as an aid in the management of vitamin K antagonist therapy. The derived fibrinogen result is intended as an aid in the diagnosis of a fibrinogen deficiency.

Thrombin Time

In vitro assay for the determination of Thrombin Time (TT) in human citrated plasma on the indicated cobas t analyzers.s.

vWF Act

In vitro assay for the quantitative determination of platelet glycoprotein Ib binding activity of von Willebrand factor in human citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of inherited and acquired von Willebrand Disease (vWD).

Information taken from respective method sheets